Search In this Thesis
   Search In this Thesis  
العنوان
Molecular characterization of Olfactory Bulb Neural Stem Cells During Proliferation And Differentiation /
الناشر
Heba Mohamed Mohamed El-Fatiry،
المؤلف
El-Fatiry, Heba Mohamed Mohamed.
هيئة الاعداد
باحث / Heba Mohamed Mohamed El-fatiry
مشرف / Entsar Ali Saad
مشرف / Hany El-Sayed Marei
مناقش / Faten Zahran Mohammed
الموضوع
Gene expression. Oligodendrocytes.
تاريخ النشر
2017.
عدد الصفحات
124 ص. :
اللغة
الإنجليزية
الدرجة
ماجستير
التخصص
Biochemistry
تاريخ الإجازة
20/2/2018
مكان الإجازة
جامعة دمياط - كلية العلوم - الكيمياء
الفهرس
Only 14 pages are availabe for public view

from 146

from 146

Abstract

This study aimed to demonstrate the fate of human olfactory bulb neural stem cells (hOBNSCs). Reported¬ly, these cells can be expanded in vitro under prolonged mitogen stimulation without propensity to transform.
Materi¬al and methods: We assessed their possible ability to proliferate and differentiate into different neurons, oligodendro¬cytes and astrocytes through monitoring changes in expression profile of proliferation (NES, NR4A1, SOX2, MSI1) and differentiation (FOXO4, CSPG4, MAP2, GFAP)-related genes.
Results: In vitro induction of hOBNSCs prolif¬eration by addition of basic fibroblast growth factor (bFGF), epidermal growth factor (EGF), and leukemia inhibitory factor (LIF) to basal serum-free medium (DMEM/F12) resulted in significant up-regulation of proliferation-related genes. Differentiation of hOBNSCs, which was initiated by replacing bFGF and EGF by triiodothyronine (T3), sig-nificantly increased expression of differentiation-related genes. Among the differentiated cells, GFAP-expressing as¬trocytes constituted the highest population of cells followed by CSPGS-expressing immature oligodendrocytes, then MAP2-expressing immature neurons, and finally FOXO4-expressing mature oligodendrocytes.
Conclusion: These data will enable us to understand the mechanism of proliferation and differentiation of hOBNSCs before and after their engraftment during cell-based therapy for neurodegenerative diseases.